Celecoxib analogs bearing benzofuran moiety as cyclooxygenase-2 inhibitors: Design, synthesis and evaluation as potential anti-inflammatory agents
作者:Ghaneya Sayed Hassan、Sahar Mahmoud Abou-Seri、Gehan Kamel、Mamdouh Moawad Ali
DOI:10.1016/j.ejmech.2014.02.033
日期:2014.4
The most potent and selective COX-2 inhibitors – compounds 3c, 3d, 3e, 9c and 9d – were assessed for their anti-inflammatory activity and ulcerogenic liability in vivo. The 3-(pyridin-3-yl)pyrazole derivatives 3c and 3e exhibited the highest anti-inflammatory activity, that is equipotent to celecoxib. Furthermore, the tested compounds proved to have better gastric safety profile compared to celecoxib
合成了具有苯并呋喃部分3a - e和9a - d的新系列塞来昔布类似物,并对其体外COX-1 / COX-2抑制活性进行了评估。评估了最有效和选择性最强的COX-2抑制剂-化合物3c,3d,3e,9c和9d的体内抗炎活性和致溃疡作用。3-(吡啶-3-基)吡唑衍生物3c和3e具有最高的抗炎活性,相当于塞来昔布。此外,与塞来昔布相比,被测化合物具有更好的胃安全性。特别地,相对于参考药物,化合物3e显示出致溃疡的可能性降低了约40%。最后,在COX-2活性位点和药物相似性研究中对新化合物进行了分子对接模拟,结果与所获得的药理生物学结果吻合良好。